2023.09.08 Grand Notice of Adoption being seleced for “Deep Tech Startup Support Program” by New Energy and Industrial Technology Development Organization (NEDO)
2023.04.13 Event SONIRE’s Clinical Trial Protocol for HIFU therapy in Pancreatic Cancer to be Presented at ISTU2023
2023.01.31 Press release Announcement of First Patient Enrolled in a Randomized Phase 2 study of SONIRE’s Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan
2022.03.22 Event As a result of Tohoku-Israel Startup Global Challenge Program, Tohru Satoh, President & CEO of SONIRE Therapeutics Inc., will participate in a panel discussion and startup pitch.
